References
- Akiskal HS. Subaffective disorders: Dysthymic, cyclo-thymic and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am 4:25–46, 1981
- Klein DF. Psychopharmacological treatment and de-lineation of borderline disorders. In Hartocollis J (ed): Borderline Personality Disorders. New York, Inter-national Universities Press, 1977.
- Soloff PH, George A, Nathan RS, et al. Progress in pharmacotherapy of borderline patients. Arch Gen Psychiatry 43:691–697, 1986
- Kernberg 0. Borderline personality organization. J Am Psychoanal Assoc 15:641-685, 1967
- Gunderson JG, Elliot GR. The interface between bor-derline personality disorder and affective disorder. Am J Psychiatry 142:277–288, 1985
- Akiskal HS, Hirschfeld RMA, Yerevanian BI. The re-lationship of personality to affective disorders: A crit-ical review. Arch Gen Psychiatry 40:801–810, 1983
- Charney DS, Nelson JC, Quinlan DM. Personality traits and disorder in depression. Am J Psychiatry 138:896–903, 1981
- Weissman MM, Prusoff BA, Klerman GL. Personality and the prediction of long-term outcome of depres-sion. Am J Psychiatry 135:797–809, 1978
- Friedman P.C. Aronoff MS, Clarkin IF: History of su-icidal behavior in depressed borderline patients. Am J Psychiatry 140:1023–1026, 1983
- Hirschfeld R, Klerman GL, Clayton PJ, et al. Assessing personality: Effects of the depressive state on trait measurement. Am J Psychiatry 140:695–699, 1984
- American Psychiatric Association. Diagnostic and Sta-tistical Manual of Mental Disorders, 3rd ed rev. Wash-ington, DC, American Psychiatric Press, 1987
- Endicott J, Spitzer RL, Fleiss J. The global assessment scale: A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766–771, 1976
- Alnaes R, Torgensen S. DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an out-patient population. Acta Psychiatr Scand 78:348–355, 1988
- Kane JM, Smith JM. Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473–481, 1982
- Pfohl B, Stangl D, Zimmerman M. The implications of DSM-III personality disorders for patients with ma-jor depression. J Affect Dis 7:309–318, 1984
- Brinkley J, Beitman BD, Friedel RO. Low dose neu-roleptic regimens in the treatment of borderline pa-tients. Arch Gen Psychiatry 36:319–326, 1979
- Gunderson JG. Pharmacotherapy for patients with borderline personality disorder. Arch Gen Psychiat 43: 698–700, 1986
- Marcus E, Bradley S. Concurrence of Axis I and Axis II illness in treatment-resistant hospitalized patients. Psychiat Clin North Am 10:177–184, 1987
- Carpenter M, Mulligan J, Bader A. Multiple admis-sions to an urban psychiatric center: A comprehensive study. Hosp Community Psychiatry 36:1305–1308, 1985
- Koenigsberg HW, Kaplan RD, Gilmore MM, et al. The relationship between syndrome and personality dis-order in DSM III: Experience with 2,462 patients. Am J Psychiatry 142:207–212, 1985
- Reich J. Sex distribution of DSM-III personality dis-orders in psychiatric outpatients. Am J Psychiatry 144: 485–488, 1987
- Kroll J, Sines L, Martin K. Borderline personality dis-order: Construct validity of the concept. Arch Gen Psychiatry 38:1021–1026, 1981
- Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH treat-ment of depression collaborative research program. Am J Psychiatry 147:711–718, 1990
- Gardner DL, Cowdry RW. Alprazolam-induced dys-control in borderline personality disorder. Am J Psy-chiatry 142:98–100, 1985
- Mellsop G, Varghese MB, Stephen J. The reliability of Axis II of DSM-III. Am J Psychiatry 139:1360–1361, 1982